Home Indexes Ideas and Research Alerts Portfolios My tickerspy newswire
QQQQ: 47.35 +0.38% | SPY: 115.45 +0.42%
Quote Spy CELG NEW Message Board  
Click to close X

Visit a stock's Spy page to see who else is tracking it and who else is talking about it. Spy pages also list institutional holders.



Enter Tickers





   

Celgene Corp (CELG)

 
Click the portfolio to add CELG:
Close [X]
+ Add CELG to Portfolio
Last Trade: 61.30 -0.61 (-0.99%) @ 4:00 PM

3-Month Chart (Larger chart w/volume)

Close [X]

1m  3m  6m  1y  2y 
Volume: 2,999,903 Avg Volume: 2,923,000
Day's Range: 60.74 - 61.92 52-wk Range: 36.90 - 62.16
Open: 61.55 Market Cap: 28.4B
Previous Close: 61.91 P/E: 36.6
Bid: 61.38 x 3 Div Yield: $0.00 (0.00%)
Ask: 61.50 x 4    
Spy CELG
To see which Pros and tickerspy members own CELG Sign up now
Indexes
Biotechnology Stocks (+0.3%)
Additional CELG resources



Customize Links
Latest CELG Notes & Links
View: Headlines   |   Message Board   |   Portfolio Notes  

Searching For Growth And Value In Biotech
AMGN  GENZ  CELG  BIIB  GILD  
Linked by Investopedia Stock Analysis - March 09, 11:27AM from (stocks.investopedia.com)
With health care reform ever present in the news, what are the prospects for biotech firms?  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Celgene Reports Record Fourth Quarter and Full Year 2009 Product Sales and Operating Income
CELG  
Linked by BusinessWire - January 28, 07:30AM from (www.businesswire.com)
Celgene Corporation (NASDAQ: CELG): 2009 Fourth Quarter Financial Results Year-Over-Year: Non-GAAP Total Revenue Increased  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Celgene Corporation to Announce Fourth Quarter and Full-Year 2009 Results on January 28, 2010
CELG  
Linked by BusinessWire - January 19, 07:30AM from (www.businesswire.com)
Celgene Corporation (NASDAQ: CELG) senior management will host a conference call and live audio webcast on Thursday, January  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Reuters BreakingViews: At Genzyme, a Long View
GENZ  CELG  MEDI  BIIB  BARE  
Linked by NYTimes - January 17, 10:11PM from (feeds.nytimes.com)
Investors shouldn’t put Genzyme on the block. The company should divest its noncore businesses and fix its manufacturing  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Celgene Completes Acquisition of Gloucester Pharmaceuticals
CELG  
Linked by BusinessWire - January 15, 07:30AM from (www.businesswire.com)
Celgene Corporation (NASDAQ: CELG) today announced it has closed its acquisition of Gloucester Pharmaceuticals following  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Flying With Airlines, Apple And Google
AMR  BA  DAL  EK  F  IBM  MRK  BAC  XRX  CAL  AAPL  LCC  MSFT  CELG  GS  NOK  COF  YHOO  RIMM  RIG  CRM  GOOG  
Linked by Forbes - January 14, 10:13AM from (www.forbes.com)
Airlines are the antithesis of great growth stocks, but why fight the market when it rewards speculation?  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Celgene remains in an uptrend
CELG  
Linked by BloggingStocks - December 21, 05:00PM from (www.bloggingstocks.com)
Celgene Corp's (CELG) stock has encountered resistance at $58, but I'm nevertheless reiterating my buy rating for the company's  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Celgene Blood Cancer Drug Found Effective
CELG  
Linked by BloggingStocks - December 18, 01:00PM from (www.bloggingstocks.com)
Celgene (CELG - option chain) shares are rising today after a late-stage study of its blood cancer drug Revlimid was found  more ...
Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Top 10 Analyst Upgrades, Downgrades, Initiations
NTRS  BP  MU  EMC  CELG  POT  NTAP  RIMM  AOL  
Linked by 24/7 Wall St. - December 18, 08:01AM from (247wallst.com)
These are this Friday's top analyst upgrades, downgrades, and initiations seen in Wall Street research calls:
AOL Inc. (NYSE: AOL) Started as Neutral at Goldman Sachs.
 more ...

Post a comment
Please flag this item as:
Close [X]
Spam
Duplicate post
Inappropriate content
Other
Upon clicking, our editors will review the post. Thanks for making tickerspy.com a more informative community.
Page 1 2 3 4 5 6 7 8 9 ... 12


 




 

 

 

 

 

 

Close [X]
Select the external links you'd like on the quote and portfolio pages. We recommend 5 to 6 links. Request a new resource.
Profile/Financials
Yahoo! Profile
Yahoo! Key Stats
MSN Financials

Analysts
Nasdaq Analysts
Yahoo! Estimates
Charts / TA
Clearstation
Google Charts
StockCharts

Subscription
Insiderscore
10k Wizard
CallStreet
Other
Short Interest
SEC Filings
Insiders
Fool CAPS


Request a new resource